1
/
of
1
Elabscience
SKU:PKSV030309
Recombinant SARS-CoV-2 Nucleocapsid Protein(Active)
Recombinant SARS-CoV-2 Nucleocapsid Protein(Active)
Regular price
$260.00 USD
Regular price
Sale price
$260.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
The Recombinant SARS-CoV-2 Nucleocapsid Protein (Active) is a cutting-edge product designed to aid in the research and development of diagnostics, vaccines, and therapeutics for the novel coronavirus, SARS-CoV-2. This high-quality protein is produced using advanced recombinant DNA technology, ensuring its purity, stability, and functionality.
The SARS-CoV-2 Nucleocapsid Protein is a crucial component of the viral structure, playing a pivotal role in viral replication and packaging of the viral RNA genome. This active form of the protein is carefully engineered to retain its native conformation and biological activity, making it an ideal tool for studying the virus's life cycle and its interactions with host cells. Researchers can utilize this protein to investigate the mechanisms of viral pathogenesis, host immune responses, and potential therapeutic targets.
With its exceptional purity and stability, the Recombinant SARS-CoV-2 Nucleocapsid Protein (Active) offers numerous applications in the field of COVID-19 research. It can be employed in various assays, including enzyme-linked immunosorbent assays (ELISA), Western blotting, and immunofluorescence, enabling accurate detection and quantification of viral antigens. Additionally, this protein serves as a valuable antigen for the development of serological tests, aiding in the identification of individuals with past or current SARS-CoV-2 infections.
In conclusion, the Recombinant SARS-CoV-2 Nucleocapsid Protein (Active) is a state-of-the-art product that provides researchers with a reliable and versatile tool for studying the novel coronavirus. Its purity, stability, and native conformation ensure accurate and reproducible results, making it an indispensable resource for the development of diagnostics, vaccines, and therapeutics. By facilitating a deeper understanding of SARS-CoV-2, this protein contributes to the global efforts in combating the COVID-19 pandemic.
The SARS-CoV-2 Nucleocapsid Protein is a crucial component of the viral structure, playing a pivotal role in viral replication and packaging of the viral RNA genome. This active form of the protein is carefully engineered to retain its native conformation and biological activity, making it an ideal tool for studying the virus's life cycle and its interactions with host cells. Researchers can utilize this protein to investigate the mechanisms of viral pathogenesis, host immune responses, and potential therapeutic targets.
With its exceptional purity and stability, the Recombinant SARS-CoV-2 Nucleocapsid Protein (Active) offers numerous applications in the field of COVID-19 research. It can be employed in various assays, including enzyme-linked immunosorbent assays (ELISA), Western blotting, and immunofluorescence, enabling accurate detection and quantification of viral antigens. Additionally, this protein serves as a valuable antigen for the development of serological tests, aiding in the identification of individuals with past or current SARS-CoV-2 infections.
In conclusion, the Recombinant SARS-CoV-2 Nucleocapsid Protein (Active) is a state-of-the-art product that provides researchers with a reliable and versatile tool for studying the novel coronavirus. Its purity, stability, and native conformation ensure accurate and reproducible results, making it an indispensable resource for the development of diagnostics, vaccines, and therapeutics. By facilitating a deeper understanding of SARS-CoV-2, this protein contributes to the global efforts in combating the COVID-19 pandemic.
Share
